These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1897431)

  • 1. Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
    Onodera K; Shinoda H
    Agents Actions; 1991 May; 33(1-2):143-6. PubMed ID: 1897431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholingeric drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone.
    Ahtee L
    Eur J Pharmacol; 1976 Oct; 39(2):203-13. PubMed ID: 987911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice.
    Shibata K; Yamada K; Furukawa T
    Psychopharmacology (Berl); 1987; 91(3):288-92. PubMed ID: 2882538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.
    Roldán G; Bolaños-Badillo E; González-Sánchez H; Quirarte GL; Prado-Alcalá RA
    Neurosci Lett; 1997 Jul; 230(2):93-6. PubMed ID: 9259472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antidepressants and antihistaminics on catalepsy induced by intracerebroventricular administration of histamine in mice.
    Onodera K
    Methods Find Exp Clin Pharmacol; 1991; 13(6):397-403. PubMed ID: 1679150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
    Taniguchi R; Nakagawasai O; Tan-no K; Yamadera F; Nemoto W; Sato S; Yaoita F; Tadano T
    Biosci Biotechnol Biochem; 2013; 77(2):266-70. PubMed ID: 23391905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA.
    Ionov ID; Severtsev NN
    Psychopharmacology (Berl); 2012 Sep; 223(2):191-7. PubMed ID: 22526536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4.
    Karasawa H; Taketo MM; Matsui M
    Eur J Pharmacol; 2003 May; 468(1):15-9. PubMed ID: 12729838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
    Kobayashi T; Araki T; Itoyama Y; Takeshita M; Ohta T; Oshima Y
    Life Sci; 1997; 61(26):2529-38. PubMed ID: 9416775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy.
    Alcock SJ; Hemsley KM; Crocker AD
    Eur J Pharmacol; 2001 Jul; 424(3):179-87. PubMed ID: 11672560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
    Yamada K; Furukawa T
    Pharmacology; 1982; 24(3):147-55. PubMed ID: 7200248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S; Mishra RK
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grooming behavior induced by ACTH involves cerebral cholinergic neurons and muscarinic receptors.
    Dunn AJ; Vigle G
    Neuropharmacology; 1985 Apr; 24(4):329-31. PubMed ID: 2987726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.
    Erzin-Waters C; Muller P; Seeman P
    Can J Physiol Pharmacol; 1976 Aug; 54(4):516-9. PubMed ID: 10058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
    Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.
    Fink-Jensen A; Schmidt LS; Dencker D; Schülein C; Wess J; Wörtwein G; Woldbye DP
    Eur J Pharmacol; 2011 Apr; 656(1-3):39-44. PubMed ID: 21269601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor.
    Kimura Y; Ohue M; Kitaura T; Kihira K
    Brain Res; 1999 Jul; 834(1-2):6-12. PubMed ID: 10407088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice.
    Nasu R; Matsuo H; Takanaga H; Ohtani H; Sawada Y
    Biopharm Drug Dispos; 2000 May; 21(4):129-38. PubMed ID: 11180191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.